Preventing HIV with a Pill
A single pill could soon become an important tool in the fight against HIV.
Hep C Type 3 Treatment Approved
The U.S. Food and Drug Administration today approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections.
FDA Approves Novel Hep C Rx
The U.S. Food and Drug Administration today approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and poor liver function (cirrhosis).
Hep C Estimates Could Be Way Off
Knowing how common a certain condition is can help prepare health care systems to treat patients. But the estimates for one disease may be way off.
Some Patients Might Not Know They Have HIV
Patients with HIV are now able to live longer and healthier lives than ever before — but only when their HIV status is known and treated.
HPV Vaccine: How Many Doses Does It Really Take?
Doctors don't usually encourage patients to deviate from their vaccination schedules, but new evidence suggests that less may actually be more — at least when it comes to the HPV vaccine.
Why Early HIV Treatment Matters
There may be some good news for HIV patients — starting medication immediately after diagnosis may help keep patients healthy longer.
Trio Treatment Showed Promise for Hep C
Three may be a crowd when it comes to company, but it might be an ideal number when it comes to medication for treating hepatitis C.
Cirrhosis Survival Spiked
Good news for cirrhosis patients: Survival may be much more common than it once was.
This Rx Combo Fought Hep C
Hepatitis C patients may soon have another medication option.